-
John Blazeck
Lablog4-63：Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzyme
Authors John Blazeck, Christos S. Karamitros, Kyle Ford, Catrina Somody, Ahlam Qerqez, Kyle Murray, Nathaniel […] -
John Blazeck
Lablog4-52：Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme.
Authors Todd A Triplett, Kendra C Garrison, Nicholas Marshall, Moses Donkor, John Blazeck, Candice Lamb, Ahlam […]
